Evaluating the role of serum uric acid in the risk stratification and therapeutic response of patients with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD)
Background: Pulmonary arterial hypertension (PAH) is a malignant pulmonary vascular disease that negatively impacts quality of life, exercise capacity, and mortality. This study sought to investigate the relationship between serum uric acid (UA) level and the disease severity and treatment response...
Saved in:
Main Authors: | Jun Luo (Author), Yuanchang Li (Author), Jingyuan Chen (Author), Haihua Qiu (Author), Wenjie Chen (Author), Xiaoqin Luo (Author), Yusi Chen (Author), Yingjie Tan (Author), Jiang Li (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Differences in right ventricular function and response to targeted therapy between patients with IPAH and PAH-CHD
by: Tengteng Zhu, et al.
Published: (2023) -
The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-word Prospective Study
by: Yusi Chen, et al.
Published: (2022) -
Corrigendum: The Transition From Ambrisentan to Macitentan in Patients With Pulmonary Arterial Hypertension: A Real-Word Prospective Study
by: Yusi Chen, et al.
Published: (2022) -
PAHs and the Universe
by: Joblin, C.
Published: (2011) -
Rapid detection of PAH gene mutations in Chinese people
by: Xin Zhang, et al.
Published: (2019)